BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8637713)

  • 1. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
    Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
    Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells.
    Ghanem L; Steinman RA
    Leuk Res; 2006 Oct; 30(10):1285-92. PubMed ID: 16499966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-myb alters the response of myeloid precursor cells to G-CSF.
    Engelhard A; Campbell K; Calabretta B
    Exp Cell Res; 2000 Jan; 254(1):153-62. PubMed ID: 10623475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
    Bies J; Mukhopadhyaya R; Pierce J; Wolff L
    Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
    Tokita K; Maki K; Mitani K
    Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation.
    Khanna-Gupta A; Sun H; Zibello T; Lozovatsky L; Ghosh PK; Link DC; McLemore ML; Berliner N
    J Leukoc Biol; 2006 May; 79(5):1011-21. PubMed ID: 16641140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
    Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
    Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.
    Dong F; Pouwels K; Hoefsloot LH; Rozemuller H; Löwenberg B; Touw IP
    Exp Hematol; 1996 Feb; 24(2):214-20. PubMed ID: 8641344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.
    Kohzaki H; Ito K; Huang G; Wee HJ; Murakami Y; Ito Y
    Oncogene; 1999 Jul; 18(28):4055-62. PubMed ID: 10435586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation.
    Wimmer K; Vinatzer U; Zwirn P; Fonatsch C; Wieser R
    Biochem Biophys Res Commun; 1998 Nov; 252(3):691-6. PubMed ID: 9837768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation.
    Shimizu S; Nagasawa T; Katoh O; Komatsu N; Yokota J; Morishita K
    Biochem Biophys Res Commun; 2002 Apr; 292(3):609-16. PubMed ID: 11922610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
    Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B
    EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
    Redell MS; Tsimelzon A; Hilsenbeck SG; Tweardy DJ
    J Leukoc Biol; 2007 Oct; 82(4):975-85. PubMed ID: 17634277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertional mutagenesis and transformation of hematopoietic stem cells.
    Ihle JN; Morishita K; Matsugi T; Bartholomew C
    Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.
    Kazama H; Kodera T; Shimizu S; Mizoguchi H; Morishita K
    Cell Growth Differ; 1999 Aug; 10(8):565-73. PubMed ID: 10470856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
    Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
    Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.